{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T18:43:51Z","timestamp":1773254631357,"version":"3.50.1"},"reference-count":32,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T00:00:00Z","timestamp":1769731200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T00:00:00Z","timestamp":1769731200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Pharmacoepidemiology and Drug"],"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Our study aimed to investigate the knowledge, attitudes, and information sources about adverse drug reactions (ADRs) among healthcare professionals (HCPs) and non\u2010healthcare professionals (non\u2010HCPs) in Poland.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A self\u2010administered questionnaire was designed in two versions (non\u2010HCPs and HCPs). The questionnaire, available in electronic and paper format, was distributed between August 2023 and April 2024 using various means, including HCP and patient organisations, senior citizens centres, and community pharmacies. The anonymous survey included a series of statements regarding ADRs and single\u2010 and multiple\u2010choice questions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Answers collected from 981 non\u2010HCPs and 481 HCPs were analysed. Most respondents correctly identified the essential aspect of the ADR definition regardless of their medical education (non\u2010HCP,\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009700 (71.36%) vs. HCP,\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009346 (71.93%)\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.818). Still, few respondents in both groups identified additional elements of the definition, with less than one\u2010third of HCP respondents believing an ADR can result from improper medication use (non\u2010HCP,\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009338 (34.45%) vs. HCP,\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009128 (26.61%)\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.002). Most respondents did not identify a \u201ccommon ADR\u201d as defined in the current rules of communicating about the frequency of ADRs. Most respondents indicate a lack of specific information in summary of product characteristics or package leaflet, with only 15.46% (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009226) stating that they believe nothing is missing from those resources.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our survey results show the need to effectively educate HCPs and non\u2010HCPs on ADRs. Exploring ways to communicate about ADRs may help patients and HCPs better understand the risks of pharmacotherapy and their role in the pharma covigilance system.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/pds.70312","type":"journal-article","created":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T10:53:10Z","timestamp":1769770390000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Knowledge, Attitudes and Sources of Information About Adverse Drug Reactions\u2014A Survey Study Among Patients and Healthcare Professionals in Poland"],"prefix":"10.1002","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5869-1340","authenticated-orcid":false,"given":"Magdalena","family":"Niedzielko","sequence":"first","affiliation":[{"name":"Department of Experimental and Clinical Pharmacology, Faculty of Medicine Medical University of Warsaw  Warsaw Poland"},{"name":"Polish Society of Pharmacovigilance  Warsaw Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5615-367X","authenticated-orcid":false,"given":"Iwona","family":"Kiersnowska","sequence":"additional","affiliation":[{"name":"Department of Propaedeutics of Nursing, Faculty of Health Sciences Medical University of Warsaw  Warsaw Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2485-5834","authenticated-orcid":false,"given":"Lucyna","family":"Kwie\u0107kowska","sequence":"additional","affiliation":[{"name":"Department of Propaedeutics of Nursing, Faculty of Health Sciences Medical University of Warsaw  Warsaw Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-2420-3121","authenticated-orcid":false,"given":"Agata","family":"Maciejczyk","sequence":"additional","affiliation":[{"name":"Polish Society of Pharmacovigilance  Warsaw Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-4073-8233","authenticated-orcid":false,"given":"Marcin","family":"Kruk","sequence":"additional","affiliation":[{"name":"Polish Society of Pharmacovigilance  Warsaw Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-9729-8096","authenticated-orcid":false,"given":"Anna","family":"Arcab","sequence":"additional","affiliation":[{"name":"Polish Society of Pharmacovigilance  Warsaw Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-7722-0020","authenticated-orcid":false,"given":"Monika","family":"Trojan","sequence":"additional","affiliation":[{"name":"Polish Society of Pharmacovigilance  Warsaw Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-4622-2781","authenticated-orcid":false,"given":"Anastazja","family":"Markowska","sequence":"additional","affiliation":[{"name":"Polish Society of Pharmacovigilance  Warsaw Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0558-4194","authenticated-orcid":false,"given":"Alicja","family":"Baranowska","sequence":"additional","affiliation":[{"name":"Municipal Hospital in Siemianowice \u015al\u0105skie  Siemianowice \u015al\u0105skie Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6294-3256","authenticated-orcid":false,"given":"Dagmara","family":"Mirowska\u2010Guzel","sequence":"additional","affiliation":[{"name":"Department of Experimental and Clinical Pharmacology, Faculty of Medicine Medical University of Warsaw  Warsaw Poland"},{"name":"Polish Society of Pharmacovigilance  Warsaw Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2026,1,30]]},"reference":[{"key":"e_1_2_9_2_1","unstructured":"European Union \u201cConsolidated Text: Directive 2001\/83\/EC of the European Parliament and of the Council of 6 November 2001 on the Community Code Relating to Medicinal Products for Human Use \u201dhttps:\/\/eur\u2010lex.europa.eu\/eli\/dir\/2001\/83\/2022\u201001\u201001."},{"key":"e_1_2_9_3_1","unstructured":"European Union \u201cRegulation (EU) No 1027\/2012 of the European Parliament and of the Council of 25 October 2012 Amending Regulation (EC) No 726\/2004 as Regards Pharmacovigilance Text With EEA Relevance \u201dhttps:\/\/eur\u2010lex.europa.eu\/eli\/reg\/2012\/1027\/oj."},{"key":"e_1_2_9_4_1","unstructured":"\u201cUstawa z dnia 5 grudnia 1996 r. o zawodach lekarza i lekarza dentysty \u201d[The Act on the Professions of Physician and Dentist] Dz.U. 2024 Item 1287."},{"key":"e_1_2_9_5_1","unstructured":"\u201cUstawa z dnia 15 lipca 2011 r. o zawodach piel\u0119gniarki i po\u0142o\u017cnej \u201d[The Act on the Professions of Nurse and Midwife] Dz.U. 2024 Item 814."},{"key":"e_1_2_9_6_1","unstructured":"\u201cUstawa z dnia 15 wrze\u015bnia 2022 r. o medycynie laboratoryjnej \u201d[The Act on Laboratory Medicine] Dz.U. 2022 Item 2280."},{"key":"e_1_2_9_7_1","unstructured":"\u201cUstawa z dnia 10 grudnia 2020 r. o zawodzie farmaceuty \u201d[The Act on the Profession of Pharmacist] Dz.U. 2024 Item 676."},{"key":"e_1_2_9_8_1","unstructured":"\u201cUstawa z dnia 1 grudnia 2022 r. o zawodzie ratownika medycznego oraz samorz\u0105dzie ratownik\u00f3w medycznych \u201d[The Act on the Profession of Paramedic and the Self\u2010Government of Paramedics] Dz.U. 2022 item 2705."},{"key":"e_1_2_9_9_1","unstructured":"\u201cUstawa z dnia 6 wrze\u015bnia 2001 r. Prawo Farmaceutyczne \u201d[Pharmaceutical Law Act] Dz.U. 2001 Vol. 126 Item 1381 With Amendments."},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.1080\/10408398.2021.1926904"},{"key":"e_1_2_9_11_1","unstructured":"\u201cEudraLex\u2010Volume 2\u2010Pharmaceutical Legislation on Notice to Applicants and Regulatory Guidelines for Medicinal Products for Human Use Volume 2C\u2010Regulatory Guideline Guideline on Summary of Product Characteristics\u2010SmPC (September 2009) \u201daccessed January 4 2025 https:\/\/health.ec.europa.eu\/document\/download\/6a043dea\u20107d0f\u20104252\u2010947b\u2010cef58f53d37e_en?filename=smpc_guideline_rev2_en.pdf."},{"key":"e_1_2_9_12_1","unstructured":"\u201cEudraLex\u2010Volume 2\u2010Pharmaceutical Legislation on Notice to Applicants and Regulatory Guidelines for Medicinal Products for Human Use Volume 2C\u2010Guideline on the Packaging Information of Medicinal Products for Human Use Authorised by the Union (September 2023\u2010Revision 14.8) \u201daccessed January 10 2025 https:\/\/health.ec.europa.eu\/document\/download\/1a633be0\u201001a7\u201041e4\u2010850f\u2010fdd3f191495b_en?filename=2018_packaging_guidelines_en_1.pdf."},{"key":"e_1_2_9_13_1","unstructured":"\u201cThe European Medicines Agency's (EMA) Working Group on Quality Review of Documents (QRD) Product\u2010Information Annotated Template (English) Version 10.4 \u201daccessed January 6 2025 https:\/\/www.ema.europa.eu\/en\/documents\/template\u2010form\/qrd\u2010product\u2010information\u2010annotated\u2010template\u2010english\u2010version\u2010104_en.pdf."},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11096\u2010023\u201001592\u2010y"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40264\u2010023\u201001302\u20107"},{"key":"e_1_2_9_16_1","unstructured":"\u201cCentrum Badania Opinii Spo\u0142ecznej (CBOS) [The Public Opinion Research Center] \u201daccessed January 25 2025 https:\/\/www.cbos.pl\/PL\/badania\/metody_realizacji.php."},{"key":"e_1_2_9_17_1","unstructured":"\u201cHealth and Health Care in 2021 Statistics Poland. Statistical Office in Krak\u00f3w 2022 \u201daccessed January 27 2025 https:\/\/stat.gov.pl\/en\/topics\/health\/health\u2010and\u2010health\u2010care\u2010in\u20102021 1 14.html."},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.sapharm.2018.03.066"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.1002\/nur.20147"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.21315\/eimj2019.11.2.6"},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00228\u2010018\u20102500\u2010y"},{"key":"e_1_2_9_22_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmacy9030147"},{"key":"e_1_2_9_23_1","unstructured":"Najwy\u017csza Izba Kontroli \u201cMonitorowanie niepo\u017c\u0105danych dzia\u0142a\u0144 lek\u00f3w: informacja o wynikach kontroli [Supreme Audit Office. Monitoring of Adverse Drug Reactions: Report on Audit Findings] Nr ewid. 164\/2020\/P\/19\/097\/LPO \u201dWarszawa Poland: Najwy\u017csza Izba Kontroli; 2020 Polish."},{"key":"e_1_2_9_24_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11606\u2010021\u201007050\u20107"},{"key":"e_1_2_9_25_1","doi-asserted-by":"publisher","DOI":"10.3238\/arztebl.2013.0669"},{"key":"e_1_2_9_26_1","doi-asserted-by":"publisher","DOI":"10.2174\/0115748863276456231016062628"},{"key":"e_1_2_9_27_1","doi-asserted-by":"publisher","DOI":"10.1080\/03007995.2021.1997287"},{"key":"e_1_2_9_28_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40264\u2010021\u201001098\u20104"},{"key":"e_1_2_9_29_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00228\u2010024\u201003729\u2010y"},{"key":"e_1_2_9_30_1","doi-asserted-by":"publisher","DOI":"10.3390\/healthcare11081133"},{"key":"e_1_2_9_31_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0285811"},{"key":"e_1_2_9_32_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12913\u2010022\u201007720\u20100"},{"key":"e_1_2_9_33_1","doi-asserted-by":"publisher","DOI":"10.2147\/RMHP.S484223"}],"container-title":["Pharmacoepidemiology and Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/pds.70312","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/pds.70312","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/pds.70312","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T01:12:16Z","timestamp":1773191536000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/pds.70312"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,30]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["10.1002\/pds.70312"],"URL":"https:\/\/doi.org\/10.1002\/pds.70312","archive":["Portico"],"relation":{},"ISSN":["1053-8569","1099-1557"],"issn-type":[{"value":"1053-8569","type":"print"},{"value":"1099-1557","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,30]]},"assertion":[{"value":"2025-03-17","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-12-19","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-01-30","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e70312"}}